460 related articles for article (PubMed ID: 24796747)
1. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
Qian H; Liu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
[TBL] [Abstract][Full Text] [Related]
2. [Protective effect of hydrogen sulfide on mice with experimental viral myocarditis and its mechanism].
Qian H; Liu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):708-12. PubMed ID: 25001934
[TBL] [Abstract][Full Text] [Related]
3. [Effects of emodin on IL-23/IL-17 inflammatory axis, Th17 cells and viral replication in mice with viral myocarditis].
Jiang N; Liao W; Kuang X
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):373-8. PubMed ID: 24670452
[TBL] [Abstract][Full Text] [Related]
4. [Effect of IL-17A on levels of antiheart autoantibodies in mice with viral myocarditis].
Lai W; Wu W; Pan X; Kong Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):601-3, 607. PubMed ID: 24909282
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.
Yu XH; Li SJ; Chen RZ; Yang YZ; Zhang P
Chin Med J (Engl); 2012 Jan; 125(1):50-5. PubMed ID: 22340465
[TBL] [Abstract][Full Text] [Related]
6. The heart-protective mechanism of Qishaowuwei formula on murine viral myocarditis induced by CVB3.
Fengqin L; Yulin W; Xiaoxin Z; Youpeng J; Yan C; Qing-qing W; Hong C; Jia S; Lei H
J Ethnopharmacol; 2010 Feb; 127(2):221-8. PubMed ID: 19932162
[TBL] [Abstract][Full Text] [Related]
7. [Interleukin-17 contributes to the macrophage secretion of interleukin-27 in a murine model of viral myocarditis].
Kong Q; Gao M; Xue Y; Pan X; Lai W; Wu W
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):428-32. PubMed ID: 25042924
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice.
Zhang H; Song Y; Zhang Z
Am J Med Sci; 2012 Sep; 344(3):206-10. PubMed ID: 22197982
[TBL] [Abstract][Full Text] [Related]
9. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
Chang H; Han B; Han XZ
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
[TBL] [Abstract][Full Text] [Related]
10. Blockade of interleukin-17A protects against coxsackievirus B3-induced myocarditis by increasing COX-2/PGE2 production in the heart.
Xie Y; Chen R; Zhang X; Yu Y; Yang Y; Zou Y; Ge J; Chen H; Garzino-Demo A
FEMS Immunol Med Microbiol; 2012 Apr; 64(3):343-51. PubMed ID: 22141571
[TBL] [Abstract][Full Text] [Related]
11. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis.
Yuan J; Yu M; Lin QW; Cao AL; Yu X; Dong JH; Wang JP; Zhang JH; Wang M; Guo HP; Cheng X; Liao YH
J Immunol; 2010 Oct; 185(7):4004-10. PubMed ID: 20802148
[TBL] [Abstract][Full Text] [Related]
12. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
13. Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway.
Song Y; Ge W; Cai H; Zhang H
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):560-9. PubMed ID: 24057864
[TBL] [Abstract][Full Text] [Related]
14. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA Ameliorate Coxsackie Virus B3-Induced Viral Myocarditis through the Inhibition of Inflammation and Modulation T Helper 1/T Helper 2 Balance in Mice.
Guo G; Zhao Q; Wang Q; Li E
Pharmacology; 2019; 103(3-4):136-142. PubMed ID: 30602153
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.
Zhang YY; Li JN; Xia HH; Zhang SL; Zhong J; Wu YY; Miao SK; Zhou LM
Life Sci; 2013 Jul; 92(24-26):1186-94. PubMed ID: 23702425
[TBL] [Abstract][Full Text] [Related]
17. CTLA4-Ig relieves inflammation in murine models of coxsackievirus B3-induced myocarditis.
Han B; Jiang H; Liu Z; Zhang Y; Zhao L; Lu K; Xi J
Can J Cardiol; 2012; 28(2):239-44. PubMed ID: 22336520
[TBL] [Abstract][Full Text] [Related]
18. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
19. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.
Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ
Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989
[TBL] [Abstract][Full Text] [Related]
20. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]